menu
    • menu

    Company profile for Cytovia Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cytovia aims to accelerate patient access to transformational cell therapies and immunotherapies, addressing several of the most challenging unmet medical needs in cancer and severe acute infectious diseases. Cytovia primarily focuses on Natural Killer (NK) cell biology and applies precision medicine tools to develop the right therapy for the right patient at the right stage of the disease. Cytovia has secured access to multip...
    Cytovia aims to accelerate patient access to transformational cell therapies and immunotherapies, addressing several of the most challenging unmet medical needs in cancer and severe acute infectious diseases. Cytovia primarily focuses on Natural Killer (NK) cell biology and applies precision medicine tools to develop the right therapy for the right patient at the right stage of the disease. Cytovia has secured access to multiple advanced technologies, including an induced pluripotent stem cell (iPSC) platform for NK cell therapy, gene editing of Chimeric Antigen Receptors (CAR) to enhance targeting of NK cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cytovia TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Brickell Bayview Center 80 SW 8th Street Suite 2000 Miami, FL 33130
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cytoviatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cytoviatherapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/CytoviaT

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cytovia Presents New Data on CD38-Targeted Flex-NK Bispecific Antibody
    Cytovia Presents New Data on CD38-Targeted Flex-NK Bispecific Antibody

    09 Dec 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cytovia-therapeutics-presents-new-data-on-cd38-targeted-flex-nk-bispecific-antibody-at-2022-american-society-of-hematology-annual-meeting-301698987.html

    PRNEWSWIRE
    09 Dec 2022
    Share Share
    Cytovia Therapeutics Presents Data on CD38-Targeted Flex-NK Bispecific Antibody
    Cytovia Therapeutics Presents Data on CD38-Targeted Flex-NK Bispecific Antibody

    09 Dec 2022

    // BIONJ

    https://bionj.org/news/pr-newswire-global?rkey=20221209FL60813&filter=16221

    BIONJ
    09 Dec 2022
    Share Share
    Cytovia Presents Data on TALEN Gene-Edited iNK Cells and GPC3
    Cytovia Presents Data on TALEN Gene-Edited iNK Cells and GPC3

    07 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cytovia-therapeutics-presents-new-data-on-talen-gene-edited-ink-cells-and-gpc3-targeted-flex-nk-bispecific-antibodies-at-2022-sitc-annual-meeting-301669887.html

    PRNEWSWIRE
    07 Nov 2022
    Share Share
    Cytovia To Present New Data on CD38 Flex-NK Cell Engager Bispecific Antibodies
    Cytovia To Present New Data on CD38 Flex-NK Cell Engager Bispecific Antibodies

    27 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cytovia-therapeutics-to-present-new-data-on-cd38-flex-nk-cell-engager-bispecific-antibodies-for-multiple-myeloma-at-2022-ash-annual-meeting-301661737.html

    PRNEWSWIRE
    27 Oct 2022
    Share Share
    Cytovia Presents Data for GPC3 Flex-NK Cell Engager Antibody
    Cytovia Presents Data for GPC3 Flex-NK Cell Engager Antibody

    12 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cytovia-therapeutics-presents-new-preclinical-data-for-its-gpc3-flex-nk-cell-engager-antibody-in-combination-with-natural-killer-cells-at-esmo-2022-in-paris-301621698.html

    PRNEWSWIRE
    12 Sep 2022
    Share Share
    Cytovia presents antitumor activity of CD38-Targeting Flex-NK Cell Engager Ab
    Cytovia presents antitumor activity of CD38-Targeting Flex-NK Cell Engager Ab

    10 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cytovia-therapeutics-presents-antitumor-activity-of-its-cd38-targeting-flex-nk-cell-engager-antibody-at-eha-2022-congress-301565565.html

    PRNEWSWIRE
    10 Jun 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search